Collectively, our results reveal what we believe to be a previously unrecognized link between activation of type I IFN signaling in cancer cells and induction of Serpinb9, which protects cancer cells from CD8+ T cell–mediated cytotoxicity after irradiation. The gene discussed is CD8A; the disease is cancer.